Cargando…

Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung fibrosis with a high mortality rate. This study aimed to uncover the underlying molecular features for different types of IPF. IPF microarray datasets were retrieved from GEO databases. Weighted gene co-expression analysis (WGCNA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuxia, Xu, Chang, Gao, Wenxin, Liu, Huaqiong, Li, Chenglong, Chen, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308534/
https://www.ncbi.nlm.nih.gov/pubmed/35919036
http://dx.doi.org/10.1155/2022/7448481
_version_ 1784753002134896640
author Liu, Yuxia
Xu, Chang
Gao, Wenxin
Liu, Huaqiong
Li, Chenglong
Chen, Mingwei
author_facet Liu, Yuxia
Xu, Chang
Gao, Wenxin
Liu, Huaqiong
Li, Chenglong
Chen, Mingwei
author_sort Liu, Yuxia
collection PubMed
description Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung fibrosis with a high mortality rate. This study aimed to uncover the underlying molecular features for different types of IPF. IPF microarray datasets were retrieved from GEO databases. Weighted gene co-expression analysis (WGCNA) was used and identified subgroup-specific WGCNA modules. Infiltration-level immune cells in different subgroups of microenvironments were analyzed with CIBERSORT algorithms. The result is we classified 173 IPF cases into two subgroups based on gene expression profiles, which were retrieved from the GEO databases. The SGRQ score and age were significantly higher in C2 than in C1. Using WGCNA, five subgroup-specific modules were identified. M4 was mainly enriched by MAPK signaling, which was mainly expressed in C2; M1, M2, and M3 were mainly enriched by metabolic pathways and Chemokine signaling, and the pathway of M5 was phagosome inflammation; M1, M2, M3, and M5 were mainly expressed in C1. Utilizing the CIBERSORT, we showed that the number of M1 macrophage cells, CD8 T cells, regulatory T cells (Tregs), and Plasma cells was significantly different between C1 and C2. We found the molecular subgroups of IPF revealed that cases from different subgroups may have their unique patterns and provide novel information to understand the mechanisms of IPF itself.
format Online
Article
Text
id pubmed-9308534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93085342022-08-01 Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis Liu, Yuxia Xu, Chang Gao, Wenxin Liu, Huaqiong Li, Chenglong Chen, Mingwei Genet Res (Camb) Research Article Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung fibrosis with a high mortality rate. This study aimed to uncover the underlying molecular features for different types of IPF. IPF microarray datasets were retrieved from GEO databases. Weighted gene co-expression analysis (WGCNA) was used and identified subgroup-specific WGCNA modules. Infiltration-level immune cells in different subgroups of microenvironments were analyzed with CIBERSORT algorithms. The result is we classified 173 IPF cases into two subgroups based on gene expression profiles, which were retrieved from the GEO databases. The SGRQ score and age were significantly higher in C2 than in C1. Using WGCNA, five subgroup-specific modules were identified. M4 was mainly enriched by MAPK signaling, which was mainly expressed in C2; M1, M2, and M3 were mainly enriched by metabolic pathways and Chemokine signaling, and the pathway of M5 was phagosome inflammation; M1, M2, M3, and M5 were mainly expressed in C1. Utilizing the CIBERSORT, we showed that the number of M1 macrophage cells, CD8 T cells, regulatory T cells (Tregs), and Plasma cells was significantly different between C1 and C2. We found the molecular subgroups of IPF revealed that cases from different subgroups may have their unique patterns and provide novel information to understand the mechanisms of IPF itself. Hindawi 2022-07-16 /pmc/articles/PMC9308534/ /pubmed/35919036 http://dx.doi.org/10.1155/2022/7448481 Text en Copyright © 2022 Yuxia Liu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Yuxia
Xu, Chang
Gao, Wenxin
Liu, Huaqiong
Li, Chenglong
Chen, Mingwei
Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
title Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
title_full Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
title_fullStr Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
title_full_unstemmed Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
title_short Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
title_sort transcriptome classification reveals molecular subgroups in idiopathic pulmonary fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308534/
https://www.ncbi.nlm.nih.gov/pubmed/35919036
http://dx.doi.org/10.1155/2022/7448481
work_keys_str_mv AT liuyuxia transcriptomeclassificationrevealsmolecularsubgroupsinidiopathicpulmonaryfibrosis
AT xuchang transcriptomeclassificationrevealsmolecularsubgroupsinidiopathicpulmonaryfibrosis
AT gaowenxin transcriptomeclassificationrevealsmolecularsubgroupsinidiopathicpulmonaryfibrosis
AT liuhuaqiong transcriptomeclassificationrevealsmolecularsubgroupsinidiopathicpulmonaryfibrosis
AT lichenglong transcriptomeclassificationrevealsmolecularsubgroupsinidiopathicpulmonaryfibrosis
AT chenmingwei transcriptomeclassificationrevealsmolecularsubgroupsinidiopathicpulmonaryfibrosis